SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-24-012789
Filing Date
2024-10-01
Accepted
2024-10-01 17:54:39
Documents
1
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 WVE - CHANGE IN BENEFICIAL OWNERSHIP wve-form4_092724.html 4  
1 WVE - CHANGE IN BENEFICIAL OWNERSHIP wve-form4_092724.xml 4 3483
  Complete submission text file 0001999371-24-012789.txt   5664
Mailing Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG
Business Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG 011442080475000
GSK plc (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 241344647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)